Game,

Thanks for the link to Cardiogenics Press Release. It provides information on a projected start date (July 10-31, 2013) and identifies the potential patient enrollment rates (15-25 patients per week) the company adopted in its development planning of the Beta Site Study. Unfortunately, it also confirms that the study has not yet begun to enroll patients.

IMO CGNH shareholders should not and the share price will not respond positively to this announcement.

Ante